Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD07805/47 (Brimonidine) Dose-Finding in Rosacea
NCT00989014Phase 2Completed
- Sponsor
- Galderma
- Start
- Sep 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine transdermal lotion in rosacea, sponsored by Galderma. Started Sep 2009; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT00989014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989014.